Memorial Sloan-Kettering Cancer Center signs agreement with gene regulation specialist Genomatix

02-Dec-2004

Genomatix Software GmbH, Munich, Germany and the Memorial Sloan-Kettering Cancer Center (MSKCC), New York, signed an agreement which allows full and unlimited access to GenomatixSuite for all over 1,300 MSKCC clinical and research staff, fellows and studentsresidents and clinical fellows as well as all students at the Center.

GenomatixSuite contains databases and analysis tools centered on gene regulatory networks and pathways and plus contains the largest available database of real mammalian promoter DNA sequences. Understanding Gene regulation is pivotal for understanding causes for diseases like cancer.

"I am delighted by this set up, which was initiated and is coordinated by the profoundly well-versed MSKCC's specialist Bioinformatics Core facility. Genomatix definitely will dedicate substantial resources to strengthen this relationship. We plan for joint seminars at MSKCC in order to educate more students in the very complex area of mammalian gene regulation." says Klaus May, Director Sales & Marketing of Genomatix.

He continues:" We are working towards expansion of this agreement to all researchers of Rockefeller University and the Cornell Weill Medical College"

Other news from the department science

Most read news

More news from our other portals

Fighting cancer: latest developments and advances